The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Jan Apelqvist


Default user image.

Effectiveness of interventions to enhance healing of chronic foot ulcers in diabetes : a systematic review


  • Prashanth Vas
  • Gerry Rayman
  • Ketan Dhatariya
  • Vickie Driver
  • Agnes Hartemann
  • Magnus Londahl
  • Alberto Piaggesi
  • Jan Apelqvist
  • Chris Attinger
  • Fran Game

Summary, in English

The management of diabetic foot ulcers (DFU) remains a challenge, and there is continuing uncertainty concerning optimal approaches to wound healing. The International Working Group of the Diabetic Foot (IWGDF) working group on wound healing has previously published systematic reviews of the evidence in 2008, 2012 and 2016 to inform protocols for routine care and to highlight areas which should be considered for further study. The working group has now updated this review by considering papers on the interventions to improve the healing of DFU's published between June 2014 and August 2018. Methodological quality of selected studies was independently assessed by a minimum of two reviewers using the recently published 21-point questionnaire as recommended by IWGDF/European Wound Management Association, as well as the previously incorporated Scottish Intercollegiate Guidelines Network criteria. Of the 2275 papers identified, 97 were finally selected for grading following full text review. Overall, there has been an improvement in study design and a significant rise in the number of published studies. While previous systematic reviews did not find any evidence to justify the use of newer therapies, except for negative pressure wound therapy in post-surgical wounds, in this review we found additional evidence to support some interventions including a sucrose-octasulfate dressing, the combined leucocyte, fibrin and platelet patch as well as topical application of some placental membrane products, all when used in addition to usual best care. Nonetheless, the assessment and comparison of published trials remains difficult with marked clinical heterogeneity between studies: in patient selection, study duration, standard of usual care provision and the timing and description of the clinical endpoints.


  • Diabetes lab
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • Genomics, Diabetes and Endocrinology

Publishing year





Diabetes/Metabolism Research and Reviews





Document type

Journal article


John Wiley & Sons Inc.


  • Endocrinology and Diabetes


  • debridement
  • diabetic foot
  • dressing
  • foot ulcer
  • guidelines
  • hyperbaric oxygen
  • negative pressure wound therapy
  • placental-derived products
  • topical oxygen
  • wound healing



Research group

  • Diabetes lab
  • Genomics, Diabetes and Endocrinology


  • ISSN: 1520-7552